New Delhi: Serum Institute of India (SII) has decided to cut production of COVID-19 vaccine, Covishield, by as much as 50 per cent as there aren’t any further orders from the Centre.
“Reducing production by at least 50 per cent starting next week as we have no further orders from the government,” SII CEO Adar Poonawalla said in an exclusive conversation with Shereen Bhan, Managing Editor, CNBC-TV18 on Tuesday.
He, however, said he wants to keep excess capacity in case the nation needs a huge amount of stock. “Hope it never happens, but I don’t want to be in a situation where we can’t provide vaccines over the next 6 months,” Poonawalla said. He also said they would stockpile 20-30 million doses of Sputnik light vaccine and won’t “take too many risks”. “As soon as we get a license, we can produce at a very high rate,” he said.
New York: After observing sand tiger sharks along the coast of North Carolina, scientists have…
Raipur: In a macabre crime, the parents and brother of a journalist were brutally killed…
Mumbai: Star couple Alia Bhatt and Ranbir Kapoor’s wedding was one of the most talked-about…
Bhubaneswar: The Odisha government has brought out the calendar for the New Year 2025. The…
Hyderabad: The highly-anticipated political drama ‘Game Changer’, starring Ram Charan and Kiara Advani, hit theatres…
New York: Ten days before he is due to enter the White House to start…
This website uses cookies.
